PMXSF (Syntara) FFO


PMXSF Syntara Ltd PMXSF
13 GF Score
Price $0.03
! 1 Warning Sign
View Full Analysis

What is Syntara FFO?

FFO (Funds from operations) only applies to REITs.

PMXSF
13GF Score
Syntara Ltd PMXSF
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Syntara Business Description

Other Exchanges UUDA:GermanySNT:Australia
Address 20 Rodborough Road, Unit 2, Frenchs Forest, Sydney, NSW, AUS, 2086
Syntara Ltd is a clinical-stage drug development company working to bring new and life-changing treatments to patients in need. It is targeting extracellular matrix dysfunction with its expertise in amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis. The company has various drug candidates in its pipeline such as SNT-5505, SNT-4728, SNT-5382, and SNT-8370 as a potential treatment for cancer, skin scarring and neuroinflammation.
13GF Score

Get the complete analysis for PMXSF

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.03
Price